Today’s Market Recap: AI, IPOs and Supply Chain Risks

Don’t Stop Here

More To Explore

BTIG Sticks Buy on ADPT: Don’t Miss Out!

Reaffirmed Bullish Stance Amid Strategic Moves BTIG Research recently reiterated its “Buy” rating on Adaptive Biotechnologies (NASDAQ: ADPT) with a $22 price target (www.streetinsider.com). This